Observational Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026 [Associations of candidate gene polymorphisms, gut microbiota, and their interactions with NAFLD in obese children]. Wei C, Pan X, Liu Y, et al. Bacteroides PubMed ↗
Review FASEB journal · 2026 The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics. Zhu S, Zou M, Wu Q, et al. Akkermansia muciniphila PubMed ↗
Systematic review Current obesity reports · 2026 The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review. González-González A, Soria-Utrilla V, Fontalba-Romero MI, et al. Faecalibacterium prausnitzii PubMed ↗
Observational BMC microbiology · 2025 High alcohol-producing Escherichia coli causes obesity and steatotic liver disease in a non-alcoholic cohort -a preclinical study. Singh A, Singh DN, Singh AN, et al. Escherichia coli PubMed ↗
Observational Journal of translational medicine · 2025 Characterization of the gut virome in patients with nonalcoholic fatty liver disease. Wang L, Wang L, Liu M, et al. Faecalibacterium PubMed ↗
Systematic review BMC gastroenterology · 2025 Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review. Asghari P, Ahmadi-Khorram M, Hatami A, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Journal of agricultural and food chemistry · 2025 Hydroxytyrosol Improves Metabolic Dysfunction-Associated Fatty Liver Disease Dependent on the Modulation of Gut Microbiota. Xiao Y, Zhang X, Shao B, et al. Fusicatenibacter saccharivorans PubMed ↗
Observational mSystems · 2025 Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease. Du L, Zhang K, Liang L, et al. [Ruminococcus] torques PubMed ↗
Review Iranian biomedical journal · 2025 Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease. Yaghmaei H, Taromiha A, Nojoumi SA, et al. Faecalibacterium PubMed ↗
Observational Environmental health and preventive medicine · 2025 A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population. Sato S, Iino C, Sasada T, et al. Blautia PubMed ↗
Review Probiotics and antimicrobial proteins · 2024 Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics. Singh V, Mahra K, Jung D, et al. Faecalibacterium PubMed ↗
Meta-analysis PloS one · 2024 Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis. Cai W, Qiu T, Hu W, et al. Faecalibacterium PubMed ↗
Observational Atherosclerosis · 2024 A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD. Li Z, Gong R, Chu H, et al. Faecalibacterium PubMed ↗
Review Current nutrition reports · 2024 The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence. Vallianou NG, Kounatidis D, Psallida S, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Review Hepatology communications · 2024 Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease. Long Q, Luo F, Li B, et al. Akkermansia muciniphilaFaecalibacterium PubMed ↗
Randomized trial Romanian journal of internal medicine = Revue roumaine de medecine interne · 2024 The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial. Mitrović M, Dobrosavljević A, Odanović O, et al. Faecalibacterium PubMed ↗
Review Bioorganic chemistry · 2024 Effects of selenium nanoparticles produced by Lactobacillus acidophilus HN23 on lipid deposition in WRL68 cells. Lei X, Peng Y, Li Y, et al. Lactobacillus acidophilus PubMed ↗
Review Archives of microbiology · 2024 Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets. Gruzdev SK, Podoprigora IV, Gizinger OA Escherichia coliKlebsiella pneumoniae PubMed ↗
Observational Wiadomosci lekarskie · 2024 Differentiated approach to management of patients with irritable bowel syndrome and ulcerative colitis in non-alcoholic fatty liver disease. Sirchak YS, Kornash VV, Dutko OO, et al. Escherichia coli PubMed ↗
Randomized trial The American journal of clinical nutrition · 2023 Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Chooi YC, Zhang QA, Magkos F, et al. Bifidobacterium adolescentis PubMed ↗